Designed for use in the first phase of the post-operative period, it is intended to be used in the building in the morning, thus providing effective compression and control in the manufacture. The high waist design provides extra stability and comfort.
Shape & colors
The compression broek is made of high-quality microfiber, which ensures a comfortable and comfortable fit. The high waist and wide elastic band is attached to the bovenzijde to ensure that the broek is good on the plaats. Verkrijgbaar in the color black and beige.
Type of closure
The compressiebroek has a pre-opening with ritssluiting, which is aan- uittrekken vermakkelijkt and zorgt voor gebruiksgemak tijdens de manufacturing period.
Customization and advice
The Marena heren compressiebroek is available in different materials and has optimal fitting guarantees. Raadpleeg de maattabel for detailed information about the juiste maatkeuze. For personal advice you can contact us via email, telephone or chat.
Product description
This compressive broek provides a compressed pressure of 17-20 mmHg, which helps in reducing the pressure and the front of a gezond during surgery. The cruise is for a zij-opening for extra work. The combination of comfort and functionality ensures that the broek is suitable for manufacturing periods.
Available 7 days a week for product advice
Express delivery or pick up possible
Product warranty during your recovery
Support for your wound healing.
Marena
a leading brand in medical compression clothing, known for its wide collection of innovative products that offer comfort, functionality, and therapeutic benefits. Using their patented "F5-compression" fabric, Marena's compression clothing promotes healthy blood circulation, reduces swelling, and accelerates the recovery process after surgeries. Worldwide, many hospitals choose Marena due to its proven effectiveness in supporting healing after surgical procedures. With a focus on quality and continuous innovation, Marena remains a reliable choice for both medical professionals and patients globally.